Stakeholders want more clarity about devices used for remote clinical studies

Regulatory NewsRegulatory NewsClinical TrialsCombination ProductsMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyResearch, Design and Development